Aarhus University Seal / Aarhus Universitets segl

Welcome to 


Center for Quantitative Genetics and Genomics (QGG) is an international research center with more than 70 employees and visitors from more than 20 nations world wide.

AT QGG we do basic and applied research within quantitative genetics and genomics. We particularly work with the development of statistical models to be used in animal and plant breeding, studies of the genetic basis for different traits and diseases, and management of genetic resources. Our main focus is animals and plants, but we are increasingly working with human genetics and model organisms. Our research is characterised by a very close collaboration with researchers and industry partners all over the world.

In the menu to the left and below, you can read more about who we are what we do, and which species we work with.

If you have any questions, you are welcome to contact us.


Photo: Lars Kruse

2019.02.27 | Research

Both the climate and farm economy can come out on top

Senior researcher at QGG, Peter Løvendahl, is the leading author of a scientific article which concludes that with the aid of low-cost, high-capacity recording methods, dairy cattle farmers can reduce the amount of greenhouse gases that their cows burp, while at the same time improving the animals’ feed efficiency.

Photo: Pixabay.com

2018.12.17 | Research

Methane from cow burps can be reduced by a two-front approach

Combing a cow’s own genetics with strategies that target changes in her rumen flora may be able to reduce methane emissions more effectively than by only selecting for low methane-emitting cows.

2018.12.07 | Grant

Huge economic potential in a better use of cross breeding in dairy cattle

The research project DairyCross, which recently received a large grant from GUDP, has a clear objective of increasing the percentage of Danish crossbred cows from 10 to 50 percent in 2025. (External article in Danish)

Graphical representation of the three contributing mechanisms assumed to cause drug response variability. Mechanism 1: A set of disease associated genetic variants are decisive for the risk of developing the disease, and the response to drug treatment varies among cases as a consequence of genetic variation in genes in e.g. drug metabolic pathways. Consequently, the rate and amount at which the body absorbs drugs varies among cases leading to variation in drug response, hence, the disease and drug response phenotypes are effectively two traits that genetically are uncoupled. Mechanism 2: The drug response variability is a consequence of variability in the disease per se, i.e. there are disease heterogeneity among the cases, which results in differences in response to treatment. The disease heterogeneity is not a result of genetic variation among the cases, but due to different lifestyle choices, different environmental exposures, and different genetic risks for correlated diseases. Mechanism 3: Heterogeneity in the associated genetic variants that causes the same disease results in variation in how individuals respond to the same medical treatment.

2018.11.23 | Grant

The personalised medicine

A new research project will be studying the genetic basis of why individuals with the same diagnosis respond differently to the same medicine. The research results can contribute to personalised medicine in the future, based on our unique genetic profile. Medicine with more effect and less side effects.


Tue 22 Oct
08:00-18:00 | Herning, Danmark
SEGES Pig Congress
The Congress focuses on professional progress, future possibilities for development and current recommendations for the pig producers.
Sun 03 Jul
08:00-16:00 | Rotterdam, The Netherlands
The next World Congress of Genetics Applied to Livestock Production will be held from 3 to 8 July 2022 in Rotterdam, The Netherlands.